Annual Total Long Term Liabilities
$270.64 M
+$29.75 M+12.35%
31 December 2023
Summary:
ProShares UltraPro Short Nasdaq Biotechnology annual total long term liabilities is currently $270.64 million, with the most recent change of +$29.75 million (+12.35%) on 31 December 2023. ZBIO annual total long term liabilities is now at all-time high.ZBIO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$0.00
-$449.63 M-100.00%
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology quarterly total long term liabilities is currently $0.00, with the most recent change of -$449.63 million (-100.00%) on 30 September 2024. Over the past year, it has dropped by -$270.47 million (-100.00%). ZBIO quarterly long term liabilities is now -100.00% below its all-time high of $449.63 million, reached on 30 June 2024.ZBIO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZBIO Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.3% | -100.0% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ZBIO Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +12.3% | -100.0% | |
| 5 y | 5 years | at high | +12.3% | -100.0% | |
| alltime | all time | at high | +12.3% | -100.0% |
ProShares UltraPro Short Nasdaq Biotechnology Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $0.00(-100.0%) |
| June 2024 | - | $449.63 M(+65.8%) |
| Mar 2024 | - | $271.21 M(+0.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $270.64 M(+12.3%) | $270.64 M(+0.1%) |
| Sept 2023 | - | $270.47 M |
| Dec 2022 | $240.90 M | - |
FAQ
- What is ProShares UltraPro Short Nasdaq Biotechnology annual total long term liabilities?
- What is the all time high annual total long term liabilities for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology annual total long term liabilities year-on-year change?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly long term liabilities year-on-year change?
What is ProShares UltraPro Short Nasdaq Biotechnology annual total long term liabilities?
The current annual total long term liabilities of ZBIO is $270.64 M
What is the all time high annual total long term liabilities for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high annual total long term liabilities is $270.64 M
What is ProShares UltraPro Short Nasdaq Biotechnology annual total long term liabilities year-on-year change?
Over the past year, ZBIO annual total long term liabilities has changed by +$29.75 M (+12.35%)
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly total long term liabilities?
The current quarterly long term liabilities of ZBIO is $0.00
What is the all time high quarterly long term liabilities for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high quarterly total long term liabilities is $449.63 M
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly long term liabilities year-on-year change?
Over the past year, ZBIO quarterly total long term liabilities has changed by -$270.47 M (-100.00%)